Trial
NCT03069911
Trial of OnabotulinumtoxinA for Depression in Parkinson Disease
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Parkinson Disease
Intervention
OnabotulinumtoxinA
Why stopped
Unable to recruit required participants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-06